Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

289
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

134
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Frequency and Risk Factors of Red Blood Cell Alloimmunization in Thalassemia Major Patients in Markazi province

Pages

  25-31

Abstract

 Background: Thalassemia is one of the most common genetic disorders throughout the world. Blood transfusion plays an important role in the treatment of thalassemia but it leads to numerous complications such as iron overload and alloimmunization. This study evaluated the frequency and Risk factors associated with alloimmunization in Thalassemia major patients living in Markazi province, Iran. Materials and Methods: In this descriptive study, 48 Thalassemia major patients who underwent blood transfusion at Amirkabir hospital were included. Patients' demographic data were recorded using a questionnaire. In order to perform alloimmunization screening and autoantibody assessment, patients were referred to Tehran Blood Transfusion Organization Laboratory. Results: The current study was performed on 48 patients with Thalassemia major, . The mean age of patients was 12. 5 ± 8. 3 years. Among patients 26 (54. 16%) were male and 22 (45. 83%) were female, 13 patients (27. 08%) had alloantibodies. Among 48 patients, 19 (39. 58%) had undergone splenectomy. The patients' age of the first blood transfusion ranged from 1 month to 14 months and the mean age of the first blood transfusion was 9. 5 ± 7. 08 months. The blood transfusion intervals in patients were from 21 days to 40 days and the blood volume received at each transfusion session was 10-15 cc/kg of the body weight. In the current study, the data analysis indicated no significant correlation between alloantibodies and RH phenotype (P=0. 43), patients' gender (P=0. 9), or blood groups (P=0. 4); whereas, a significant correlation was found between alloantibodies and splenectomy (P=0. 02) as an increase in the prevalence of alloantibodies was reported in splenectomised patients. Conclusion: No significant difference was found between the patients with and without alloantibodies in terms of the prevalence of Rh phenotype, gender, and blood groups. However, there was a significant difference between the patients with and without alloantibodies in terms of splenectomy.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    EGHBALI, AZIZ, Rahimi Afzal, Roghaieh, Mehrabi, Sarvenaz, Sanatkar, Seyed Amir, & Mousavi Hasanzadeh, Morteza. (2019). Frequency and Risk Factors of Red Blood Cell Alloimmunization in Thalassemia Major Patients in Markazi province. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 9(1), 25-31. SID. https://sid.ir/paper/320711/en

    Vancouver: Copy

    EGHBALI AZIZ, Rahimi Afzal Roghaieh, Mehrabi Sarvenaz, Sanatkar Seyed Amir, Mousavi Hasanzadeh Morteza. Frequency and Risk Factors of Red Blood Cell Alloimmunization in Thalassemia Major Patients in Markazi province. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY[Internet]. 2019;9(1):25-31. Available from: https://sid.ir/paper/320711/en

    IEEE: Copy

    AZIZ EGHBALI, Roghaieh Rahimi Afzal, Sarvenaz Mehrabi, Seyed Amir Sanatkar, and Morteza Mousavi Hasanzadeh, “Frequency and Risk Factors of Red Blood Cell Alloimmunization in Thalassemia Major Patients in Markazi province,” IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, vol. 9, no. 1, pp. 25–31, 2019, [Online]. Available: https://sid.ir/paper/320711/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top